EUVIMEDSkopri EUVIMED
Open access · CC BY 4.0

Podocyte specific knockout ( KO ) of the natriuretic peptide clearance receptor ( NPRC ) attenuates diabetic kidney disease ( DKD )

Liming Wang, Yupinp Tang, Qunsheng Dai, Anne F Buckley, Robert F Spurney iD

Physiological Reports · 2026-05 · 14 (9)

DOI: 10.14814/phy2.70899 ↗

At a glance

Journal article in Physiological Reports, published online on 2026-05-13. Written by Liming Wang and 4 co-authors. Institution: Division of Nephrology, Department of Medicine, Duke University and Durham VA Medical Centers, Durham, North Carolina, USA. Major MEDLINE topics: Podocytes, Diabetic Nephropathies, Receptors, Atrial Natriuretic Factor, Diabetes Mellitus, Type 1. 78 references. The full text is freely available (open access, CC BY 4.0). Funded by: BLRD VA, NCATS NIH HHS, HHS | NIH | National Center for Advancing Translational Sciences (NCATS).

AstrattSubjectsDettalji biblijografiċiCiteRelated studies

Abstract (original language)

Glomerular podocytes play a key role in the pathogenesis of diabetic kidney disease (DKD). Recent studies suggest that natriuretic peptides (NPs) are podocyte protective. The beneficial effects of NPs are inhibited by the removal of NPs from the circulation by the NP clearance receptor (NPRC). To determine if inhibiting NP clearance by NPRC ameliorated DKD, we deleted NPRC specifically in glomerular podocytes in a mouse model of type 1 diabetes (Akita mice). We found that diabetes induced a significant increase in albuminuria in WT Akita mice, which was significantly reduced by knockout (KO) of NPRC. Histologic damage was mild in both WT and KO Akita mice and limited to a modest increase in mesangial matrix in both groups. In contrast, expression of the fibrotic markers fibronectin and collagen 1 was significantly increased in isolated glomerular preparations, and expression of both fibrotic markers was significantly improved by podocyte‐specific KO of NPRC. Taken together, these data suggest that inhibiting NP clearance by glomerular podocytes has beneficial effects in a mouse model of early‐stage DKD.

Subjects

MeSH terms (MEDLINE)

PodocytesDiabetic NephropathiesReceptors, Atrial Natriuretic FactorDiabetes Mellitus, Type 1AnimalsMice, KnockoutMiceMaleDiabetes Mellitus, ExperimentalAlbuminuriaMice, Inbred C57BL

Author keywords

diabetic nephropathykidney diseasenatriuretic peptides

Substances

Receptors, Atrial Natriuretic Factoratrial natriuretic factor receptor C

Authors and institutions

  • Division of Nephrology, Department of Medicine, Duke University and Durham VA Medical Centers, Durham, North Carolina, USA.
  • Department of Pathology, Duke University Medical Center, Durham, North Carolina, USA.

ORCID profiles: Robert F Spurney

Funding

  • BLRD VA
  • NCATS NIH HHS
  • HHS | NIH | National Center for Advancing Translational Sciences (NCATS)
  • Veterans Administration Medical Center (VAMC)
  • Veterans Administration Medical Center, Yale School of Medicine
  • National Center for Advancing Translational Sciences

Cite

APA

Wang, L., Tang, Y., Dai, Q., Buckley, A. F., & Spurney, R. F. (2026). Podocyte specific knockout ( KO ) of the natriuretic peptide clearance receptor ( NPRC ) attenuates diabetic kidney disease ( DKD ). Physiological Reports, 14(9). https://doi.org/10.14814/phy2.70899

Vancouver

Wang L, Tang Y, Dai Q, Buckley AF, Spurney RF. Podocyte specific knockout ( KO ) of the natriuretic peptide clearance receptor ( NPRC ) attenuates diabetic kidney disease ( DKD ). Physiological Reports. 2026;14(9). doi:10.14814/phy2.70899

BibTeX
@article{Wang2026,
  author = {Wang, Liming and Tang, Yupinp and Dai, Qunsheng and Buckley, Anne F and Spurney, Robert F},
  title = {Podocyte specific knockout ( KO ) of the natriuretic peptide clearance receptor ( NPRC ) attenuates diabetic kidney disease ( DKD )},
  journal = {Physiological Reports},
  year = {2026},
  volume = {14},
  number = {9},
  doi = {10.14814/phy2.70899}
}
Start for free →